Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olivia Pelletier
Institution:
Disc Medicine, Inc. (United States)
Observed institution:
Disc Medicine, Inc. (United States)
OpenAlex ID:
A5069729465
A Phase 1b Study of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Myelofibrosis and Anemia
2024
·
Naseema Gangat
, James M. Foran
, et al.
·
Blood
·
11
PDF
A Phase 1b Trial of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Myelofibrosis and Anemia
2023
·
Naseema Gangat
, James M. Foran
, et al.
·
Blood
·
6
RALLY-MF: Initial efficacy of a phase 2 study of DISC-0974, an anti-hemojuvelin antibody, to treat anemia in myelofibrosis.
2026
·
Naseema Gangat
, Ayalew Tefferi
, et al.
·
Journal of Clinical Oncology
·
2
A Phase 1b Trial of DISC-0974, an Anti-Hemojuvelin Antibody, in Participants With Myelofibrosis and Anemia
2024
·
Naseema Gangat
, James Foran
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
A Phase 1b Double-Blind, Placebo-Controlled Study of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Non-Dialysis Dependent Chronic Kidney Disease and Anemia
2023
·
Samir Arora
, Jorge Monroy
, et al.
·
Blood
·
2
RALLY MF: A phase 2 Study of DISC-0974, an anti-hemojuvelin antibody, in patients with myelofibrosis and anemia
2025
·
Naseema Gangat
, Ayalew Tefferi
, et al.
·
Blood
·
1
MPN-757: A Phase 1b Trial of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients With Myelofibrosis and Anemia
2025
·
Naseema Gangat
, James Foran
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
A Phase 1b, Double-Blind, Placebo-Controlled Study of DISC-0974, an Anti-hemojuvelin Antibody, in Patients with Nondialysis-Dependent CKD and Anemia
2024
·
Samir Arora
, Pablo E. Pergola
, et al.
·
Journal of the American Society of Nephrology
·
1
ORAL ABSTRACT: MPN-120: RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis
2026
·
Naseema Gangat
, Ayalew Tefferi
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MPN-120: RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis
2026
·
Naseema Gangat
, Ayalew Tefferi
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MPN-120: RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis
2026
·
Naseema Gangat
, Ayalew Tefferi
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
A Phase 1b, Double-Blind, Placebo-Controlled Study of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Nondialysis-Dependent CKD and Anemia
2025
·
Pablo E. Pergola
, F. David Newby
, et al.
·
Journal of the American Society of Nephrology
POSTER: MPN-757 A Phase 1b Trial of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients With Myelofibrosis and Anemia
2025
·
Naseema Gangat
, James Foran
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MPN-153 A Phase 1b Trial of DISC-0974, an Antihemojuvelin Antibody, in Participants With Myelofibrosis and Anemia
2024
·
Naseema Gangat
, James Foran
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
14
Citation count:
26
H-index:
2
I10-index:
1
Year
Topic
Type
